Postherpetic Neuralgia
📧 Sign up to get email alerts when something new happens for Postherpetic Neuralgia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2025-11-24FDA Approved: GABAPENTIN — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved a supplemental application for gabapentin from Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. (ANDA211314).
-
CLINICAL_TRIALS trial_result · 2025-10-06Clinical Trial Update: Pulsed Radiofrequency in Post Herptic Neuralgia [NA]
A clinical trial sponsored by Sohag University is evaluating pulsed radiofrequency for postherpetic neuralgia and is not yet recruiting.
-
FDA approval · 2025-10-01FDA Approved: PREGABALIN — Supplemental Application (Creekwood Pharmaceuticals LLC)
The FDA approved a supplemental application for pregabalin from Creekwood Pharmaceuticals LLC under ANDA213423.
-
FDA approval · 2025-09-19FDA Approved: GABAPENTIN — Original Application (ScieGen Pharmaceuticals, Inc.)
FDA approved ScieGen Pharmaceuticals' original application for a generic gabapentin, enabling a generic version to be marketed for the same …
-
FDA approval · 2025-09-17FDA Approved: PREGABALIN — Supplemental Application (MARKSANS PHARMA LIMITED)
The FDA approved a supplemental application for pregabalin from Marksans Pharma Limited, resulting in approval of a generic pregabalin produ…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2025-09-05FDA Approved: GABARONE — Supplemental Application (INA Pharmaceutics Inc.)
FDA approved a supplemental application for GABARONE (gabapentin) by INA Pharmaceutics Inc. under ANDA211313. This action typically reflects…
-
CLINICAL_TRIALS trial_result · 2025-09-02Clinical Trial Update: Safety and Efficacy Study of KAI-1678 to Treat Pain in Subjects With Postherpetic Neuralgia [Phase 2]
A Phase 2 clinical trial evaluating KAI-1678 for pain in postherpetic neuralgia has completed.
-
FDA approval · 2025-08-26FDA Approved: GABAPENTIN — Supplemental Application (Granules Pharmaceuticals Inc)
The FDA approved a supplemental application for Gabapentin from Granules Pharmaceuticals Inc. This approval updates the product's labeling/i…
-
FDA approval · 2025-08-21FDA Approved: PREGABALIN — Supplemental Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' supplemental ANDA for pregabalin, authorizing the marketing of a generic pregabalin product.
-
FDA approval · 2025-08-21FDA Approved: PREGABALIN — Supplemental Application (ScieGen Pharmaceuticals, Inc)
FDA approved a supplemental application for pregabalin from ScieGen Pharmaceuticals, Inc., confirming approval of the generic product under …
-
FDA approval · 2025-08-18FDA Approved: PREGABALIN — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for Pregabalin submitted by Rising Pharma Holdings, Inc. under the approved ANDA.
-
FDA approval · 2025-08-15FDA Approved: PREGABALIN — Supplemental Application (Indoco Remedies Limited)
FDA approved a supplemental application for pregabalin from Indoco Remedies Limited, resulting in approval of a generic pregabalin product.
-
FDA approval · 2025-08-07FDA Approved: GABAPENTIN — Original Application (STALLION LABORATORIES PRIVATE LIMITED)
The FDA approved Stallion Laboratories Private Limited's Original Application for gabapentin, granting approval of a generic gabapentin prod…
-
CLINICAL_TRIALS research · 2025-07-28Clinical Trial Update: Clinical Trial of the Safety and Efficacy of Peripheral Nerve Stimulation in the Treatment of Peripheral Neuropathic Pain. [NA]
A clinical trial is evaluating the safety and efficacy of peripheral nerve stimulation for peripheral neuropathic pain and related condition…
-
CLINICAL_TRIALS trial_result · 2025-07-24Clinical Trial Update: A Clinical Trial to Investigate Efficacy and Safety of NT 201 Injections Compared With Placebo Injections in Participants Aged 18 Years and Older With Chronic Nerve Pain After Shingles or Nerve Injury [Phase 2]
A Phase 2 clinical trial evaluating the efficacy and safety of NT 201 injections versus placebo in adults with chronic peripheral neuropathi…
-
FDA approval · 2025-07-23FDA Approved: GABAPENTIN — Supplemental Application (Camber Pharmaceuticals, Inc.)
The FDA approved a supplemental application for gabapentin from Camber Pharmaceuticals, enabling the generic version to be marketed.
-
FDA approval · 2025-07-21FDA Approved: PREGABALIN — Supplemental Application (Alembic Pharmaceuticals Inc.)
FDA approved Alembic Pharmaceuticals' supplemental application for pregabalin. The approval enables the marketing of a generic pregabalin pr…
-
CLINICAL_TRIALS research · 2025-07-09Clinical Trial Update: Electroacupuncture for PHN: Efficacy and Biomarker Evaluation in a Multicenter, Randomized, Sham-Controlled Trial Protocol [NA]
A multicenter randomized, sham-controlled trial protocol to assess electroacupuncture for postherpetic neuralgia, including efficacy outcome…
-
CLINICAL_TRIALS research · 2025-07-08Clinical Trial Update: Closed-Loop Deep Brain Stimulation for Refractory Chronic Pain [NA]
A clinical trial evaluating closed-loop deep brain stimulation for refractory chronic pain is currently recruiting. The study lists several …
-
FDA approval · 2025-07-07FDA Approved: PREGABALIN — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approves a supplemental application for Pregabalin from Torrent Pharmaceuticals Limited, enabling the generic drug to be marketed.
-
FDA approval · 2025-07-07FDA Approved: PREGABALIN — Supplemental Application (Amneal Pharmaceuticals NY LLC)
The FDA approved a supplemental application for pregabalin filed by Amneal Pharmaceuticals NY LLC.
-
FDA approval · 2025-07-01FDA Approved: PREGABALIN CAPSULES, CV — Supplemental Application (Cipla USA Inc.)
FDA approved a supplemental application for Pregabalin Capsules, CV from Cipla USA Inc., under ANDA to market this generic pregabalin capsul…
-
CLINICAL_TRIALS research · 2025-06-26Clinical Trial Update: Early Screening Markers of Herpes Zoster Neuralgia
Clinical trial from Tongji Hospital investigating early screening markers for herpes zoster neuralgia, including postherpetic neuralgia; the…
-
CLINICAL_TRIALS research · 2025-06-05Clinical Trial Update: The Effectiveness of Ultra-Sound Guided Erector Spinae Block With Betamethasone for Management of Truncal Chronic Post Herpetic Neuralgia. [NA]
A Cairo University clinical trial evaluating ultrasound-guided erector spinae plane block with betamethasone for truncal postherpetic neural…
-
CLINICAL_TRIALS research · 2025-06-03Clinical Trial Update: Ketamine for Postherpetic Neuralgia With Depression [Phase 4]
Phase 4 clinical trial evaluating ketamine for individuals with depression and postherpetic neuralgia; the study is currently not recruiting…